The EMPEROR-Preserved Trial
August 10, 2022 | C. Michael Gibson and Stefan Anker discuss the effects of empagliflozin on CV death and HF hospitalizations in patients with HFpEF, with and without diabetes./font> |
New at TCTMD? Register today!
Enter the email you used to register to reset your password.